Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Brain Metastases
Interventions: DRUG: Nivolumab|RADIATION: Stereotactic Radiosurgery
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Bristol-Myers Squibb